Background: In older age, the benefits of antihypertensive treatment (AHT) become less evident, with greater associated risk. Of particular concern is compromising cerebral blood flow (CBF), especially in those with cognitive impairment.
Methods: We created a synthesis of the published evidence by searching multiple electronic databases from 1970 to May 2021.